Published in Acta Paediatr Scand on September 01, 1986
Effect of growth hormone on short normal children. Br Med J (Clin Res Ed) (1987) 1.55
Growth hormone (GH) provocation tests and the response to GH treatment in GH deficiency. Arch Dis Child (2004) 0.83
Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res (2000) 4.41
The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res (1998) 3.13
Body index measurements in 1996-7 compared with 1980. Arch Dis Child (2000) 2.77
Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab (2008) 2.74
Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature (1984) 2.69
Developing evidence-based guidelines for referral for short stature. Arch Dis Child (2007) 2.49
Systemic and local regulation of the growth plate. Endocr Rev (2003) 2.14
[Measuring the length of newborn infants]. Ned Tijdschr Geneeskd (2005) 1.94
Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum (2012) 1.84
Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants? Early Hum Dev (2003) 1.66
Towards evidence based referral criteria for growth monitoring. Arch Dis Child (2004) 1.59
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab (2001) 1.51
Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res (1998) 1.47
A 43-year-old male with untreated panhypopituitarism due to absence of the pituitary stalk: from dwarf to giant. J Clin Endocrinol Metab (2002) 1.46
Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science (1992) 1.45
Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girls. J Clin Endocrinol Metab (1992) 1.44
Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1-5-year-old children. Qual Life Res (2000) 1.42
Pubertal development in The Netherlands 1965-1997. Pediatr Res (2001) 1.40
The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res (1998) 1.39
[Clinical characteristics and management of adolescents admitted to the emergency ward for alcohol intoxication in the region of The Hague during the period 1999-2001]. Ned Tijdschr Geneeskd (2004) 1.39
Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature. Dutch Growth Hormone Working Group. Clin Endocrinol (Oxf) (1995) 1.39
Catch-up growth. Endocr Rev (1997) 1.38
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
A method to construct age references for skewed skinfold data, using Box-Cox transformations to normality. Hum Biol (1985) 1.32
Nationwide age references for sitting height, leg length, and sitting height/height ratio, and their diagnostic value for disproportionate growth disorders. Arch Dis Child (2005) 1.31
The human insulin-like growth factor II gene contains two development-specific promoters. FEBS Lett (1987) 1.27
Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands. Acta Paediatr (2004) 1.23
Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis. J Med Genet (2008) 1.20
Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology (1987) 1.20
An analysis of intra-uterine growth retardation in rural Malawi. Eur J Clin Nutr (2001) 1.19
[Increased prevalence of overweight and obesity in Dutch children, and the detection of overweight and obesity using international criteria and new reference diagrams]. Ned Tijdschr Geneeskd (2001) 1.18
Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett (1985) 1.18
Further purification and characterization of sulfation factor and thymidine factor from acromegalic plasma. J Clin Endocrinol Metab (1971) 1.18
Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology (1990) 1.18
Expression of Indian hedgehog, parathyroid hormone-related protein, and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth. J Bone Miner Res (2000) 1.17
Cerebral gigantism (Sotos syndrome). Compiled data of 22 cases. Analysis of clinical features, growth and plasma somatomedin. Eur J Pediatr (1985) 1.13
Symptomatology of patients with oligodontia. J Oral Rehabil (1994) 1.13
Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Dutch Growth Hormone Working Group. Acta Paediatr (1998) 1.12
Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment. Acta Paediatr (1997) 1.10
Growth of preterm born children. Horm Res (2008) 1.10
Specific endonucleolytic cleavage of IGF-II mRNAs. Biochem Biophys Res Commun (1991) 1.08
Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin Endocrinol (Oxf) (2007) 1.08
Site-specific cleavage of IGF-II mRNAs requires sequence elements from two distinct regions of the IGF-II gene. Nucleic Acids Res (1992) 1.06
High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child (2002) 1.06
The IGSF1 deficiency syndrome: characteristics of male and female patients. J Clin Endocrinol Metab (2013) 1.05
Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet (1993) 1.04
Short stature and the probability of coeliac disease, in the absence of gastrointestinal symptoms. Arch Dis Child (2004) 1.04
Biosynthetic somatomedin C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice. Pediatr Res (1986) 1.04
Defects in growth hormone receptor signaling. Trends Endocrinol Metab (2007) 1.04
Prepubertal height velocity references over a wide age range. Arch Dis Child (1992) 1.03
Genetic disorders in the growth hormone - insulin-like growth factor-I axis. Horm Res (2006) 1.03
Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia (2006) 1.01
Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. J Clin Endocrinol Metab (2009) 1.01
Myelination as an expression of the functional maturity of the brain. Dev Med Child Neurol (1991) 1.00
Diagnostic value of orthopedic tests in patients with temporomandibular disorders. J Dent Res (1993) 1.00
Adult height in patients with early onset of Crohn's disease. Gut (2002) 0.99
Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis (2000) 0.99
Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant (2004) 0.99
Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab (2001) 0.99
A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. J Clin Endocrinol Metab (2006) 0.99
Intelligence of very preterm or very low birthweight infants in young adulthood. Arch Dis Child Fetal Neonatal Ed (2008) 0.98
Immunologic studies in Turner syndrome before and during treatment with growth hormone. The Dutch Growth Hormone Working Group. J Pediatr (1991) 0.98
Genetic disorders in the GH IGF-I axis in mouse and man. Eur J Endocrinol (2007) 0.98
Genetic analysis of short stature. Horm Res (2003) 0.97
Treatment with two growth hormone regimens in girls with Turner syndrome: final height results. Dutch Growth Hormone Working Group. Horm Res (1995) 0.96
Growth curves of Dutch children with Down's syndrome. J Intellect Disabil Res (1996) 0.96
Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res (1998) 0.96
[Growth diagrams for patient care]. Tijdschr Kindergeneeskd (1985) 0.96
Quality of life in short adults. Horm Res (1998) 0.96
Mutations in mitochondrial tRNA genes: non-linkage with syndromes of Wolfram and chronic progressive external ophthalmoplegia. Nucleic Acids Res (1992) 0.95
Growth monitoring and diagnostic work-up of short stature: an international inventorization. J Pediatr Endocrinol Metab (2005) 0.94
Catch-up growth in 60 children with celiac disease. J Pediatr Gastroenterol Nutr (1994) 0.94
Psychosocial impact of acne vulgaris. evaluation of the relation between a change in clinical acne severity and psychosocial state. Dermatology (2001) 0.94
Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients. Arch Dis Child (2002) 0.93
Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method. Clin Diagn Lab Immunol (1995) 0.92
Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet (1991) 0.92
Final height after long-term growth hormone treatment in Turner syndrome. European Study Group. J Pediatr (1995) 0.92
Catch-up growth and endocrine changes in childhood celiac disease. Endocrine changes during catch-up growth. Horm Res (2002) 0.91
Testicular degeneration in three patients with the persistent müllerian duct syndrome. Eur J Pediatr (1995) 0.91
Differential polysomal localization of human insulin-like-growth-factor-2 mRNAs in cell lines and foetal liver. Eur J Biochem (1994) 0.91
The offspring of mothers with anorexia nervosa: a high-risk group for undernutrition and stunting? Eur J Pediatr (1989) 0.91
Partial characterization of sulphation and thymidine factors in acromegalic plasma. Acta Endocrinol (Copenh) (1971) 0.91
Inhibition of Gsk3β in cartilage induces osteoarthritic features through activation of the canonical Wnt signaling pathway. Osteoarthritis Cartilage (2011) 0.90
Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning. Circulation (1992) 0.90
Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. Diabetologia (1990) 0.90
Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone. J Clin Endocrinol Metab (1996) 0.90
Tall stature and duplication of the insulin-like growth factor I receptor gene. Eur J Med Genet (2006) 0.89
Sex steroid metabolism in the tibial growth plate of the rat. Endocrinology (2002) 0.89
Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr (2000) 0.89
Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group. Eur J Pediatr (1992) 0.89
Effect of growth hormone and peptide fractions containing somatomedin activity on growth and cartilage metabolism of Snell dwarfmice. Acta Endocrinol (Copenh) (1979) 0.89
Polymorphic detection of a parthenogenetic maternal and double paternal contribution to a 46,XX/46,XY hermaphrodite. Am J Hum Genet (1998) 0.89
Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods. J Epidemiol Community Health (1996) 0.88
Mutations in the NSD1 gene in patients with Sotos syndrome associate with endocrine and paracrine alterations in the IGF system. Eur J Endocrinol (2004) 0.88
Many referrals under Dutch short stature guidelines. Arch Dis Child (2004) 0.88
Value of transcranial Doppler indices in predicting raised ICP in infantile hydrocephalus. A study with review of the literature. Childs Nerv Syst (1995) 0.88